Pindolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BJ4HF6IU1D, chemically known as 2-propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)- but generally known as pindolol, which bears US NIH Compound Identifier 4828. European Medicines Agency schedules Pindolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09854MIG. The term PINDOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules pindolol in its Anatomical Therapeutic Chemical (ATC) Classification. PINDOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pindolol under HS 29339990 and SITC 51577. As of Q4 2014, PINDOLOL remains the US FDA Preferred Term for this commodity. Pindolol bears US NLM identifiers UMLS ID C0031937 and NCI Concept Code C47673. SMILES: O(CC(O)CNC(C)C)C1C2C([NH]CC2)CCC1.